National Health Investors (NYSE:NHI – Get Free Report) updated its FY 2024 earnings guidance on Monday. The company provided earnings per share guidance of 4.370-4.430 for the period, compared to the consensus earnings per share estimate of 4.350. The company issued revenue guidance of -.
Analysts Set New Price Targets
A number of research firms have weighed in on NHI. Truist Financial increased their target price on shares of National Health Investors from $55.00 to $58.00 and gave the company a hold rating in a research report on Thursday, April 4th. Wedbush boosted their target price on shares of National Health Investors from $64.00 to $66.00 and gave the company an outperform rating in a report on Monday, March 18th. BMO Capital Markets raised shares of National Health Investors from a market perform rating to an outperform rating and set a $67.00 price target on the stock in a research report on Tuesday, March 12th. Deutsche Bank Aktiengesellschaft initiated coverage on National Health Investors in a research note on Tuesday, January 30th. They issued a buy rating and a $69.00 price objective on the stock. Finally, StockNews.com cut National Health Investors from a buy rating to a hold rating in a research note on Thursday, April 18th. Five analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of Hold and a consensus price target of $60.50.
Check Out Our Latest Analysis on NHI
National Health Investors Stock Performance
National Health Investors Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 2nd. Stockholders of record on Friday, June 28th will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 5.48%. The ex-dividend date is Friday, June 28th. National Health Investors’s payout ratio is presently 115.02%.
Insider Activity at National Health Investors
In related news, Director Charlotte A. Swafford purchased 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The stock was acquired at an average price of $58.69 per share, for a total transaction of $586,900.00. Following the completion of the acquisition, the director now owns 110,185 shares of the company’s stock, valued at approximately $6,466,757.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 8.21% of the stock is owned by insiders.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Stories
- Five stocks we like better than National Health Investors
- Roth IRA Calculator: Calculate Your Potential Returns
- No New Highs for Cloudflare in 2024
- 3 Healthcare Dividend Stocks to Buy
- Electronic Arts Earnings Engaging Players and Building Value
- Transportation Stocks Investing
- 3 Tripe-Digit Growth Mid Cap Stocks to Watch This Quarter
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.